Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 70518-3304

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 70518-3304). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Atorvastatin Calcium is a medication available in tablet form with a strength of 80 mg. The National Drug Code (NDC) number for this medication is 70518-3304-00. It has to be stored at a temperature range of 20-26°C (63-77°F) with excursions permitted to 15-30°C (59-86°F) as per USP guidelines. The medication comes in a package of 30 tablets, manufactured by Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854. The medication should be kept away from the reach of children. Directions for use can be found in the package insert. The lot number is not available. The source NDC number is 72205-0025-05. The medication is repackaged by RemedyRepack Inc., Indiana, PA 15701, for distribution by prescription only.*
FDA Label Image

Figure-01 (Atorvastatin Figure 01)

FDA Label Image

Figure-02 (Atorvastatin Figure 02)

Figure-02 (Atorvastatin Figure 02)
The text contains a graph with the cumulative hazard percentage and a time axis labeled from one to five years. Additionally, there is a hazard ratio of 0.63 with a confidence interval of 0.48-0.83 and a p-value of 0.001. After the graph, there are some unreadable characters.*
FDA Label Image

Figure-03 (Atorvastatin Figure 03)

Figure-03 (Atorvastatin Figure 03)
The text describes a chart or table showing the percentage of subjects who experienced a particular event while taking different doses of Atorvastatin (10mg and 80mg). The risk of experiencing the event was significantly lower in subjects taking Atorvastatin 80mg compared to those taking 10mg. It also shows a Hazard Ratio and P-value for this comparison. The chart or table also shows the time it took for subjects to experience the event. However, the specific event or endpoint is not specified in the text, making it difficult to provide further information.*
FDA Label Image

Structure (Atorvastatin Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.